SI-BONE, Inc. (SIBN) · Sep 11, 2026 · Other events

SI-BONE recalls 98 implants over sterile-barrier failure; $150K charge estimated

98-implant recall — 98 implants recalled; up to ~$150,000 gross charge

SI-BONE disclosed a 98-implant recall tied to packaging sterility, with up to $150,000 of costs and unresolved FDA and liability risk.

The filing introduces a product-quality issue the market was not previously expecting. SI-BONE initiated a voluntary recall of 98 iFuse TORQ implants after packaging failed to meet sterile-barrier acceptance criteria. 〔0〕 There is no clean published consensus benchmark for a recall, so the relevant comparison is against the prior assumption of uninterrupted product availability and no remediation cost: this is a new negative.

ItemFiling detail
Distributed implants recalled98 (Recall disclosure)
Already implanted2 (Recall disclosure)
Implants expected to be repackaged and re-sterilizedApproximately 3,900 (Recall disclosure)
Estimated gross chargeUp to approximately $150,000 (Recall disclosure)
Expected revenue impactNone otherwise expected in Q3 (Recall disclosure)

The immediate financial damage looks contained, but the operational scope is much larger than the headline recall count. Only 98 implants had left company control, while approximately 3,900 implants may require repackaging and re-sterilization. 〔1〕 The estimated charge of up to $150,000 is modest in absolute terms, and the company says revenue should not otherwise be affected. 〔2〕

The main uncertainty is regulatory and liability exposure, not the disclosed charge. Two recalled implants were already implanted, although no infections or adverse events had been reported as of the filing date. 〔3〕 SI-BONE has requested Class II classification from the FDA, but the agency could classify the recall differently, expand its scope, or identify additional remediation requirements; the company also has not secured reimbursement from the tube manufacturer. Net, the filing is a mild negative: limited near-term financial impact, offset by a new product-quality and regulatory overhang that remains unresolved.

What to watch next

Q3 results and additional recall-impact disclosure

Original filing on SEC EDGAR

More SI-BONE, Inc. news

SI-BONE recalls 98 implants over sterile-barrier failure; $150K charge estimated | SIBN Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.